Novo Holdings Legend Biotech Corp Transaction History

Novo Holdings

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$35.31 - $50.56 $9.88 Million - $14.1 Million	-279,676 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$25.8 - $41.09 $657,900 - $1.05 Million	25,500 Added 10.03%	279,676 $11.5 Million
Q1 2021 May 17, 2021	BUY	$23.55 - $32.4 $5.99 Million - $8.24 Million	254,176 New	254,176 $7.38 Million

225

74.3M

279K

350K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.68B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

Stay updated on Novo Holdings with notifications on news.